发明公开
EP1487792A1 DIHYDROINDOL-2-ONE DERIVATIVES AS STEROID HORMONE NUCLEAR RECEPTOR MODULATORS
审中-公开
DIHYDROINDOL-2-ONDERIVATE ALS MODULATOREN DESNUKLEÄRENSTEROIDHORMONREZEPTORS
- 专利标题： DIHYDROINDOL-2-ONE DERIVATIVES AS STEROID HORMONE NUCLEAR RECEPTOR MODULATORS
- 专利标题（中）： DIHYDROINDOL-2-ONDERIVATE ALS MODULATOREN DESNUKLEÄRENSTEROIDHORMONREZEPTORS
-
申请号： EP03723665.0申请日： 2003-03-11
-
公开(公告)号： EP1487792A1公开(公告)日： 2004-12-22
- 发明人: GRESE, Timothy, Alan , JADHAV, Prabhakar, Kondaji , NEEL, David, Andrew , STEINBERG, Mitchell, Irvin , LANDER, Peter, Ambrose
- 申请人： ELI LILLY AND COMPANY
- 申请人地址： Lilly Corporate Company Indianapolis, IN 46285 US
- 专利权人： ELI LILLY AND COMPANY
- 当前专利权人： ELI LILLY AND COMPANY
- 当前专利权人地址： Lilly Corporate Company Indianapolis, IN 46285 US
- 代理机构： Burnside, Ivan John
- 优先权： US365212P 20020315
- 国际公布： WO2003078394 20030925
- 主分类号： C07D209/34
- IPC分类号： C07D209/34 ; A61K31/404 ; A61P7/10 ; A61P9/12
摘要：
he present invention relates to methods of treating pathological disorders susceptible to steroid hormone nuclear receptor modulation, particularly congestive heart failure, comprising administering to a patient in need thereof an effective amount of a compound of the formula: I or a pharmaceutically acceptable salt thereof. In addition, the present invention provides novel pharmaceutical compounds of Formula I, including the pharmaceutically acceptable salts thereof, as well as pharmaceutical compositions which comprise as an active ingredient a compound of Formula I.
信息查询
